United Therapeutics Corporation (UTHR)

NASDAQ: UTHR · IEX Real-Time Price · USD

237.00

+2.53 (1.08%)

At close: Apr 24, 2024, 4:00 PM

240.00

+3.00 (1.27%)

Pre-market: Apr 25, 2024, 7:34 AM EDT

United Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Revenue	2,328	1,936	1,686	1,483	1,449	1,628	1,725	1,599	1,466	1,289	Upgrade
Revenue Growth (YoY)	20.20%	14.88%	13.63%	2.38%	-11.00%	-5.65%	7.91%	9.07%	13.76%	15.36%	Upgrade
Cost of Revenue	257.5	151.6	122.5	108.1	117.6	198.7	105.7	72.7	69	125.9	Upgrade
Gross Profit	2,070	1,785	1,563	1,375	1,331	1,429	1,620	1,526	1,397	1,163	Upgrade
Selling, General & Admin	477.1	482.1	467	423.9	336.2	265.8	330.1	316.8	452.7	381.3	Upgrade
Research & Development	408	322.9	540.1	357.7	1,183	357.9	264.6	147.6	245.1	242.5	Upgrade
Other Operating Expenses	0	0	0	0	0	0	210	0	0	0	Upgrade
Operating Expenses	885.1	805	1,007	781.6	1,519	623.7	804.7	464.4	697.8	623.8	Upgrade
Operating Income	1,185	979.7	555.9	593.6	-187.6	805.4	814.9	1,062	699	538.8	Upgrade
Interest Expense / Income	59.3	32.4	18.6	23.5	44.2	13.9	9	3.9	4.7	17.6	Upgrade
Other Expense / Income	-148.7	-3.3	-56.6	-68.8	-66.8	32.6	36.4	-2.4	-350.1	-4	Upgrade
Pretax Income	1,274	950.6	593.9	638.9	-165	758.9	769.5	1,060	1,044	525.2	Upgrade
Income Tax	289.5	223.3	118.1	124.1	-60.5	169.7	351.6	346.5	392.8	185.1	Upgrade
Net Income	984.8	727.3	475.8	514.8	-104.5	589.2	417.9	713.7	651.6	340.1	Upgrade
Net Income Growth	35.40%	52.86%	-7.58%	-	-	40.99%	-41.45%	9.53%	91.59%	94.83%	Upgrade
Shares Outstanding (Basic)	47	46	45	44	44	44	44	44	46	48	Upgrade
Shares Outstanding (Diluted)	50	49	47	45	44	44	45	47	51	54	Upgrade
Shares Change	2.47%	2.54%	6.05%	1.83%	-0.45%	-2.00%	-4.06%	-8.59%	-5.54%	1.82%	Upgrade
EPS (Basic)	21.04	15.98	10.60	11.65	-2.39	13.54	9.50	16.29	14.17	7.06	Upgrade
EPS (Diluted)	19.81	15.00	10.06	11.54	-2.39	13.39	9.31	15.25	12.72	6.28	Upgrade
EPS Growth	32.07%	49.11%	-12.82%	-	-	43.82%	-38.95%	19.89%	102.55%	91.46%	Upgrade
Free Cash Flow	747.6	663.7	477.4	698.8	-290.3	594	396.2	605.6	333	307.9	Upgrade
Free Cash Flow Per Share	15.97	14.59	10.63	15.81	-6.63	13.65	9.01	13.83	7.24	6.39	Upgrade
Gross Margin	88.94%	92.17%	92.73%	92.71%	91.88%	87.79%	93.87%	95.45%	95.29%	90.23%	Upgrade
Operating Margin	50.91%	50.60%	32.98%	40.02%	-12.95%	49.48%	47.23%	66.41%	47.69%	41.82%	Upgrade
Profit Margin	42.31%	37.56%	28.23%	34.71%	-7.21%	36.20%	24.22%	44.64%	44.45%	26.40%	Upgrade
Free Cash Flow Margin	32.12%	34.28%	28.32%	47.11%	-20.04%	36.49%	22.96%	37.88%	22.72%	23.90%	Upgrade
Effective Tax Rate	22.72%	23.49%	19.89%	19.42%	-	22.36%	45.69%	32.68%	37.61%	35.24%	Upgrade
EBITDA	1,387	1,034	662.4	712.3	-74.9	808.7	809.5	1,096	1,082	575	Upgrade
EBITDA Margin	59.58%	53.42%	39.30%	48.02%	-5.17%	49.68%	46.92%	68.53%	73.82%	44.63%	Upgrade
Depreciation & Amortization	53.2	51.3	49.9	49.9	45.9	35.9	31	31.6	32.9	32.2	Upgrade
EBIT	1,334	983	612.5	662.4	-120.8	772.8	778.5	1,064	1,049	542.8	Upgrade
EBIT Margin	57.30%	50.77%	36.34%	44.66%	-8.34%	47.48%	45.12%	66.56%	71.57%	42.13%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).